The University of Queensland's Brain Institute's (QBI) newest MRI machine will allow researchers to monitor real time changes in the brain and spinal cord injury. Conditions likely to benefit range from Alzheimer's to Parkinson's to spinal cord injury.
The story fails to mention what, exactly, Bartlett is saying could go to human trials within two years. Based on his previous work, it's safe to assume that he is referring to a treatment for acute spinal cord injury.
If EphA4 makes no sense to you, you'll be happy to know that Bartlett provided a thorough explanation elsewhere.
After spinal cord injury in normal mice, and humans, nerve fibers called axons extend out, looking for a new connection. The growing axons hit a chemical blockade at the injury site, which prevent them from growing any further.
Bartlett developed a mouse strain that lacked the EphA4 gene to see what happened to it after a spinal cord injury.
Six weeks after the injury, analysis showed that 70% of the axons in these mice had grown through the injury site, compared to only 1 or 2% in normal mice. Three months after the injury, the mice were almost completely recovered.
The deletion of EphA4 had actually prevented the chemical blockade at the injury site (glial scar) from forming.
Chronic injuries already contain glial scars, so this therapy isn't directly applicable to those who have been paralyzed for a while like me. There's a good chance, however, that the glial scar could be removed so that the EphA4-based therapy has a chance of working.
You may have to reinjure the spinal cord slightly above and below the existing injury site, but I think the temporary inconvenience would be worth it if recovery was to follow.
New Machine Looks Closer at Brains [The Age]